New Products: Takara Bio Europe's Xfect siRNA Transfection Reagent; Exiqon's miRcury LNA microRNA Array | GenomeWeb

Takara Bio Europe has introduced the Xfect siRNA transfection reagent.

According to the company, the reagent ensures efficient delivery of siRNAs with low toxicity due to the use of biodegradable nanoparticles created by the binding of the reagent to dsRNA.


Exiqon has introduced the seventh generation of its miRcury LNA microRNA array, which includes 3,100 capture probes covering all human, mouse, and rat miRNAs in the latest version of miRBase.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.